First Midwest Bank Trust Division Has $669,000 Position in Danaher Corporation (DHR)

First Midwest Bank Trust Division lessened its position in Danaher Corporation (NYSE:DHR) by 40.6% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,809 shares of the company’s stock after selling 5,327 shares during the period. First Midwest Bank Trust Division’s holdings in Danaher Corporation were worth $669,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the stock. GQG Partners LLC acquired a new stake in shares of Danaher Corporation during the second quarter worth approximately $101,000. Proficio Capital Partners LLC raised its position in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the company’s stock valued at $105,000 after acquiring an additional 598 shares in the last quarter. Monetary Management Group Inc. raised its position in Danaher Corporation by 10.7% during the second quarter. Monetary Management Group Inc. now owns 1,550 shares of the company’s stock valued at $131,000 after acquiring an additional 150 shares in the last quarter. Acrospire Investment Management LLC raised its position in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the company’s stock valued at $143,000 after acquiring an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC bought a new position in Danaher Corporation during the first quarter valued at approximately $157,000. 75.38% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This article was originally posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://ledgergazette.com/2017/11/13/first-midwest-bank-trust-division-has-669000-position-in-danaher-corporation-dhr.html.

A number of equities analysts have recently commented on DHR shares. BidaskClub raised shares of Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Zacks Investment Research downgraded shares of Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research note on Friday, August 4th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of C$93.31.

Danaher Corporation (NYSE:DHR) opened at C$92.24 on Monday. The firm has a market capitalization of $64,162.62, a price-to-earnings ratio of 23.71, a price-to-earnings-growth ratio of 2.19 and a beta of 1.02. Danaher Corporation has a 12-month low of C$76.27 and a 12-month high of C$93.36. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42.

Danaher Corporation (NYSE:DHR) last released its earnings results on Thursday, October 19th. The company reported C$1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of C$0.95 by C$0.05. The company had revenue of C$4.53 billion for the quarter, compared to analyst estimates of C$4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. Danaher Corporation’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.87 EPS. sell-side analysts forecast that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.61%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is currently 16.52%.

In other news, CAO Robert S. Lutz sold 11,189 shares of the firm’s stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of C$91.66, for a total transaction of C$1,025,583.74. Following the completion of the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at C$1,678,661.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the firm’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of C$92.64, for a total value of C$11,671,620.96. Following the transaction, the chief executive officer now owns 271,737 shares of the company’s stock, valued at C$25,173,715.68. The disclosure for this sale can be found here. Insiders sold 279,628 shares of company stock worth $25,304,394 over the last ninety days. 12.20% of the stock is currently owned by insiders.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply